Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OvIP1: IPEC Cisplatin in Ovarian Cancer
NCT02567253Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Mar 2016
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in ovarian cancer, primary peritoneal cancer (PPC), sponsored by Ghent University Hospital. Started Mar 2016; status: completed.
02
Drugs
cisplatin
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT02567253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02567253.